AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Sierra Bancorp
BSRR
$529M
| $269K | ﹤0.01% |
10,566
-1,600
| -13% | -$43.2K |
|
3052
iShares Select Dividend ETF
DVY
$23.5B
| $269K | ﹤0.01% |
2,307
-90
| -4% | -$10.7K |
|
|
ANAC
3053
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $268K | ﹤0.01% |
+27,500
| New | +$269K |
|
|
EIGR
3054
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $267K | ﹤0.01% |
1,043
+43
| +4% | +$10.7K |
|
|
CFB
3055
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $266K | ﹤0.01% |
19,315
-4,100
| -18% | -$59.2K |
|
|
RNAM
3056
DELISTED
Avidity Biosciences
RNAM
| $264K | ﹤0.01% |
+10,700
| New | +$249K |
|
3057
CNB Financial Corp
CCNE
$1.04B
| $263K | ﹤0.01% |
11,540
-1,200
| -9% | -$29.3K |
|
3058
Luxfer Holdings
LXFR
$456M
| $263K | ﹤0.01% |
11,813
-2,200
| -16% | -$47.8K |
|
|
ETNB
3059
DELISTED
89bio
ETNB
| $262K | ﹤0.01% |
14,000
+2,200
| +19% | +$49.1K |
|
3060
Astronics
ATRO
$3.43B
| $261K | ﹤0.01% |
17,880
-3,000
| -14% | -$43.5K |
|
3061
Hingham Institution for Saving
HIFS
$623M
| $261K | ﹤0.01% |
900
-200
| -18% | -$58.8K |
|
3062
National CineMedia
NCMI
$368M
| $261K | ﹤0.01% |
5,152
-440
| -8% | -$20.6K |
|
|
ICAD
3063
DELISTED
iCAD Inc
ICAD
| $260K | ﹤0.01% |
15,000
+2,000
| +15% | +$35.1K |
|
|
FBMS
3064
DELISTED
The First Bancshares, Inc.
FBMS
| $260K | ﹤0.01% |
6,947
-2,000
| -22% | -$77.1K |
|
|
ZY
3065
DELISTED
Zymergen Inc. Common Stock
ZY
| $260K | ﹤0.01% |
+6,500
| New | +$257K |
|
3066
Autoliv
ALV
$9B
| $259K | ﹤0.01% |
2,647
| – | – |
|
3067
PAVmed
PAVM
$37.3M
| $259K | ﹤0.01% |
+90
| New | +$213K |
|
3068
Liberty Global Class C
LBTYK
$3.49B
| $258K | ﹤0.01% |
9,533
-4,641
| -33% | -$125K |
|
3069
Lexicon Pharmaceuticals
LXRX
$1.03B
| $258K | ﹤0.01% |
56,111
+12,000
| +27% | +$57.8K |
|
|
TPC
3070
Tutor Perini Cor
TPC
$4.47B
| $256K | ﹤0.01% |
18,495
-7,484
| -29% | -$119K |
|
|
OYST
3071
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $256K | ﹤0.01% |
14,900
+1,200
| +9% | +$22.8K |
|
3072
Citizens
CIA
$240M
| $255K | ﹤0.01% |
48,149
-6,260
| -12% | -$34.5K |
|
3073
Financial Institutions
FISI
$813M
| $255K | ﹤0.01% |
8,500
-10,233
| -55% | -$320K |
|
3074
Napco Security Technologies
NSSC
$1.32B
| $255K | ﹤0.01% |
14,000
-1,200
| -8% | -$20.6K |
|
3075
Ooma
OOMA
$595M
| $255K | ﹤0.01% |
13,500
+3,000
| +29% | +$54.4K |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.